Skip to main content
. 2021 Sep 10;12:741369. doi: 10.3389/fimmu.2021.741369

Figure 2.

Figure 2

Venn diagram of aPLs cross-positivity analysis in the APS group (n = 151). (A) Cross-positivity for aCL; (B) cross-positivity for aβ2GpI; (C) cross-positivity for IgG; (D) cross-positivity for IgM.